Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications.
about
Control of Body Weight by Eating Behavior in ChildrenEffect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients.Oxytocin's inhibitory effect on food intake is stronger in obese than normal-weight menInvestigational glucagon-like peptide-1 agonists for the treatment of obesity.Nanogel-based nasal ghrelin vaccine prevents obesity.
P2860
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications.
@en
type
label
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications.
@en
prefLabel
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications.
@en
P2860
P1476
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications.
@en
P2093
Alfredo Halpern
Bruno Halpern
P2860
P304
P356
10.1517/14740338.2015.994502
P407
P577
2015-01-07T00:00:00Z